Access Infinity introduces AI-powered price and HTA predictions on Nuro platform 

Access Infinity has announced the launch of an AI-enabled feature on its Nuro platform, which provides market access insights for pharmaceutical and life sciences teams. The update introduces automated predictions for drug pricing and health technology assessment (HTA) outcomes, aiming to cut a process that typically takes months down to minutes. 

One of the main challenges in pharmaceutical market access is the time and effort required to analyze complex datasets in order to predict pricing strategies and anticipate HTA outcomes. The new feature is designed to address this issue by applying AI to transform intricate drug parameters into clear, actionable insights. This allows market access teams to accelerate their strategies, reduce uncertainty, and base decisions on a stronger evidence foundation. 

Tom Gilboy, Product Owner at Access Infinity, noted the increasing adoption of AI in market access over the past year:  

“In the last 12 months in particular, we’ve seen many Market Access teams make the leap from exploring how they can adopt AI to embracing AI by integrating it into their everyday processes.”  

He explained that the new feature provides a foundation for business development and asset assessments, allowing teams to “focus on optimizing the asset itself, rather than conducting the initial estimate.” 

Keshav Nagaraja, Managing Director – Digital at Access Infinity, said the feature reflects the company’s focus on applying AI to practical challenges in market access.  

“This new feature exemplifies our commitment to pushing the boundaries of what’s possible in pharmaceutical market access intelligence,” he commented. “Our deep understanding of market access challenges, combined with innovative AI capabilities, allows us to deliver solutions that truly move the needle for our clients.” 

The AI-powered pricing and HTA predictions are now available to all Nuro users. Access Infinity expects the functionality to increase efficiency for market access teams by reducing uncertainty and supporting earlier strategic planning.